Gns561 exhibits potent antiviral activity against sars-cov-2 through autophagy inhibition

HIGHLIGHTS

• who: Eloïne Bestion and collaborators from the Institut de Recherche Pour le Développement, Aix-Marseille University, Assitance Publique-Hopitaux de Institut Hospitalo-Universitaire Méditerranée Infection, Aix-Marseille University, Marseille, France have published the paper: GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition, in the Journal: Viruses 2022, 132 of /2022/
• what: The aim of this study was to evaluate the antiviral activity of GNS561 against SARS-CoV-2 infection. The authors report that GNS561 has potent antiviral activity mediated by its ability to inhibit autophagic flux. Regarding . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.